Metropolitan Life Insurance Company (MetLife)’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,867
Closed -$93.5K 493
2024
Q1
$93.5K Buy
5,867
+21
+0.4% +$335 ﹤0.01% 1081
2023
Q4
$98.3K Hold
5,846
﹤0.01% 1093
2023
Q3
$68.3K Buy
5,846
+333
+6% +$3.89K ﹤0.01% 1219
2023
Q2
$74.1K Hold
5,513
﹤0.01% 1190
2023
Q1
$91.4K Sell
5,513
-781
-12% -$12.9K ﹤0.01% 1032
2022
Q4
$117K Hold
6,294
0.01% 971
2022
Q3
$80.8K Hold
6,294
﹤0.01% 1148
2022
Q2
$44.1K Hold
6,294
﹤0.01% 1583
2022
Q1
$52.2K Sell
6,294
-17,282
-73% -$143K ﹤0.01% 1563
2021
Q4
$160K Sell
23,576
-2,831
-11% -$19.2K ﹤0.01% 2178
2021
Q3
$140K Buy
26,407
+4,109
+18% +$21.8K ﹤0.01% 2325
2021
Q2
$128K Sell
22,298
-8,020
-26% -$46.1K ﹤0.01% 2457
2021
Q1
$140K Buy
30,318
+2,792
+10% +$12.9K ﹤0.01% 2253
2020
Q4
$91.9K Sell
27,526
-438
-2% -$1.46K ﹤0.01% 2393
2020
Q3
$83.1K Sell
27,964
-3,124
-10% -$9.28K ﹤0.01% 2320
2020
Q2
$144K Buy
31,088
+10,959
+54% +$50.6K ﹤0.01% 2032
2020
Q1
$77.5K Buy
20,129
+4,079
+25% +$15.7K ﹤0.01% 2192
2019
Q4
$60.2K Sell
16,050
-19,713
-55% -$73.9K ﹤0.01% 2482
2019
Q3
$190K Buy
35,763
+7,482
+26% +$39.7K ﹤0.01% 1914
2019
Q2
$109K Hold
28,281
﹤0.01% 2259
2019
Q1
$144K Buy
28,281
+1,028
+4% +$5.24K ﹤0.01% 2107
2018
Q4
$52.3K Hold
27,253
﹤0.01% 2505
2018
Q3
$103K Hold
27,253
﹤0.01% 2438
2018
Q2
$85K Buy
27,253
+6,885
+34% +$21.5K ﹤0.01% 2391
2018
Q1
$48.7K Sell
20,368
-1,836
-8% -$4.39K ﹤0.01% 2443
2017
Q4
$87K Buy
+22,204
New +$87K ﹤0.01% 2383
2016
Q1
Sell
-55,663
Closed -$136K 2510
2015
Q4
$136K Buy
55,663
+8,218
+17% +$20.1K ﹤0.01% 2467
2015
Q3
$142K Sell
47,445
-9,426
-17% -$28.2K ﹤0.01% 2504
2015
Q2
$235K Buy
+56,871
New +$235K ﹤0.01% 2290